Boston Scientific Corporation reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 3,725 million compared to USD 3,242 million a year ago. Net income was USD 504 million compared to USD 140 million a year ago. Basic earnings per share from continuing operations was USD 0.34 compared to USD 0.09 a year ago. Diluted earnings per share from continuing operations was USD 0.34 compared to USD 0.09 a year ago.
For the full year, sales was USD 14,240 million compared to USD 12,682 million a year ago. Net income was USD 1,593 million compared to USD 698 million a year ago. Basic earnings per share from continuing operations was USD 1.08 compared to USD 0.45 a year ago. Diluted earnings per share from continuing operations was USD 1.07 compared to USD 0.45 a year ago.